Literature DB >> 29480635

Comparative analysis of the 2016 ACR-EULAR and the 2002 AECG classification criteria for Sjögren's syndrome: Findings from the NIH cohort.

M Billings1, M Amin Hadavand1, I Alevizos1.   

Abstract

INTRODUCTION: The introduction of new classification criteria for Sjögren's syndrome, known as the 2016 American College of Rheumatology/European League against Rheumatism Classification Criteria (ACR-EULAR), created a need for the evaluation of its performance in an external cohort. The purpose of this study was to compare the performance of the 2016 ACR-EULAR classification set with the widely used American-European Consensus Group Classification criteria (AECG) in the cohort at the National Institutes of Health, USA, and to compare the performance of the sets in classifying both primary and secondary Sjögren's syndrome (pSS and sSS).
METHODS: The study cohort at the NIH (N = 1,303) was enrolled for clinical suspicion of SS. Participants were classified as SS, pSS, and sSS according to both classification sets. Performance of 2016 ACR-EULAR and AECG sets was compared holding each as gold standard to the other. Statistical analysis of test diagnostics and agreement between the two sets were undertaken.
RESULTS: By the AECG set, 701 were classified as having SS (627 pSS, 74 sSS) and 714 were classified with SS (647 pSS, 67 sSS) by the 2016 ACR-EULAR set. Sensitivity and specificity of the two sets were comparable in classifying SS, pSS, and sSS. There was high agreement between the two sets for classifying SS (κ = 0.79), pSS (κ = 0.81), and sSS (κ = 0.87). The specificity of the 2016 ACR-EULAR set was significantly higher for classifying sSS than pSS, while the sensitivity was similar for the two disease groups. However, this pattern was also exhibited by the AECG set.
CONCLUSION: There was high agreement between the two classification sets with comparable performance diagnostics. There was no evidence of superior performance value by the new 2016 ACR-EULAR set over the AECG set, and the two sets were found to be equivalent. Findings from our cohort indicate that 2016 ACR-EULAR classification could be extended to classification of sSS. Published 2018. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  ACR-EULAR; AECG; Classification Criteria; Sjögren’s Syndrome

Mesh:

Year:  2018        PMID: 29480635      PMCID: PMC5831553          DOI: 10.1111/odi.12772

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  15 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 2.  SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES.

Authors:  K J BLOCH; W W BUCHANAN; M J WOHL; J J BUNIM
Journal:  Medicine (Baltimore)       Date:  1965-05       Impact factor: 1.889

3.  American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort.

Authors:  S C Shiboski; C H Shiboski; L A Criswell; A N Baer; S Challacombe; H Lanfranchi; M Schiødt; H Umehara; F Vivino; Y Zhao; Y Dong; D Greenspan; A M Heidenreich; P Helin; B Kirkham; K Kitagawa; G Larkin; M Li; T Lietman; J Lindegaard; N McNamara; K Sack; P Shirlaw; S Sugai; C Vollenweider; J Whitcher; A Wu; S Zhang; W Zhang; J S Greenspan; T E Daniels
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-04       Impact factor: 4.794

4.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

Authors:  C Vitali; S Bombardieri; H M Moutsopoulos; G Balestrieri; W Bencivelli; R M Bernstein; K B Bjerrum; S Braga; J Coll; S de Vita
Journal:  Arthritis Rheum       Date:  1993-03

Review 5.  Sjögren's syndrome. A review with emphasis on immunological features.

Authors:  R Manthorpe; K Frost-Larsen; H Isager; J U Prause
Journal:  Allergy       Date:  1981-04       Impact factor: 13.146

6.  Sjögren's syndrome.

Authors:  M A Shearn
Journal:  Major Probl Intern Med       Date:  1971

7.  Preliminary diagnostic criteria for Sjögren's syndrome.

Authors:  F N Skopouli; A A Drosos; T Papaioannou; H M Moutsopoulos
Journal:  Scand J Rheumatol Suppl       Date:  1986

8.  Comparison of the American-European Consensus Group Sjogren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort.

Authors:  Astrid Rasmussen; John A Ice; He Li; Kiely Grundahl; Jennifer A Kelly; Lida Radfar; Donald U Stone; Kimberly S Hefner; Juan-Manuel Anaya; Michael Rohrer; Rajaram Gopalakrishnan; Glen D Houston; David M Lewis; James Chodosh; John B Harley; Pamela Hughes; Jacen S Maier-Moore; Courtney G Montgomery; Nelson L Rhodus; A Darise Farris; Barbara M Segal; Roland Jonsson; Christopher J Lessard; R Hal Scofield; Kathy L Moser Sivils
Journal:  Ann Rheum Dis       Date:  2013-08-22       Impact factor: 19.103

9.  2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts.

Authors:  Caroline H Shiboski; Stephen C Shiboski; Raphaèle Seror; Lindsey A Criswell; Marc Labetoulle; Thomas M Lietman; Astrid Rasmussen; Hal Scofield; Claudio Vitali; Simon J Bowman; Xavier Mariette
Journal:  Ann Rheum Dis       Date:  2016-10-26       Impact factor: 19.103

10.  Comparison of performance of the 2016 ACR-EULAR classification criteria for primary Sjögren's syndrome with other sets of criteria in Japanese patients.

Authors:  Hiroto Tsuboi; Shinya Hagiwara; Hiromitsu Asashima; Hiroyuki Takahashi; Tomoya Hirota; Hisashi Noma; Hisanori Umehara; Atsushi Kawakami; Hideki Nakamura; Hajime Sano; Kazuo Tsubota; Yoko Ogawa; Etsuko Takamura; Ichiro Saito; Hiroko Inoue; Seiji Nakamura; Masafumi Moriyama; Tsutomu Takeuchi; Yoshiya Tanaka; Shintaro Hirata; Tsuneyo Mimori; Isao Matsumoto; Takayuki Sumida
Journal:  Ann Rheum Dis       Date:  2017-03-22       Impact factor: 19.103

View more
  8 in total

Review 1.  Advances in the diagnosis and treatment of Sjogren's syndrome.

Authors:  Xiaoyun Chen; Huaxun Wu; Wei Wei
Journal:  Clin Rheumatol       Date:  2018-05-26       Impact factor: 2.980

2.  Clinical and serological characteristics of seronegative primary Sjögren's syndrome: a comparative study.

Authors:  Veli Yazisiz; Bengisu Aslan; Funda Erbasan; İsmail Uçar; Tahir Saygin Öğüt; Mustafa Ender Terzioğlu
Journal:  Clin Rheumatol       Date:  2020-06-05       Impact factor: 2.980

3.  Clinical and laboratory evaluation of sicca complaints: distinctive aspects of primary, secondary and non-Sjogren syndrome.

Authors:  Fabíola Reis de Oliveira; Ana Carolina F Motta; Carolina Maria Módulo; Denny Marcos Garcia; John A Chiorini; Paulo Louzada-Junior; Eduardo Melani Rocha
Journal:  Adv Rheumatol       Date:  2022-07-01

4.  Analysis of oral bacterial communities: comparison of HOMINGS with a tree-based approach implemented in QIIME.

Authors:  Robert J Palmer; Sean L Cotton; Alexis S Kokaras; Pamela Gardner; Margaret Grisius; Eileen Pelayo; Blake Warner; Bruce J Paster; Ilias Alevizos
Journal:  J Oral Microbiol       Date:  2019-04-01       Impact factor: 5.474

5.  Characteristics of dry eye in patients with pre-existing Sjögren's syndrome according to the revised 2016 ACR-EULAR classification criteria.

Authors:  Hyeon Jeong Yoon; Won Choi; Jee Myung Yang; Yong Sok Ji; Shin-Seok Lee; Kyung Chul Yoon
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

Review 6.  Indications for diagnostic use of nuclear medicine in rheumatology: A mini-review.

Authors:  Martin Wenger; Michael Schirmer
Journal:  Front Med (Lausanne)       Date:  2022-09-28

Review 7.  Recent advances in the search for a targeted immunomodulatory therapy for primary Sjögren's syndrome.

Authors:  David L Leverenz; E William St Clair
Journal:  F1000Res       Date:  2019-08-29

8.  Oral lesions in patients with primary Sjögren's syndrome. A case-control cross-sectional study.

Authors:  J Serrano; R-M López-Pintor; M Fernández-Castro; L Ramírez; M Sanz; E Casañas; J-A García; S Recuero; C Bohorquez; G Hernández
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2020-01-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.